�����������

An exciting new course opportunity titled “Commercialization of Biomedical Technologies” (GS 5109) will be offered at the Graduate School of Biomedical Sciences (GSBS) for the upcoming fourth term. The course will be sponsored by BCM Innovation Institute and led by Dr. Michael Dilling and will feature guest lectures from business and venture leaders from BCM, the TMC and beyond. Auditing participants are welcome!

• Course Title: Commercialization of Biomedical Technologies (GS 5109)
• Course Director: Michael Dilling, PhD, CLP, Executive Leader in Commercialization and Technology Management, BCM Innovation Institute
• Registration open!

Don't miss out on this valuable opportunity to expand your knowledge and network within the field of biomedical technologies. We look forward to your active participation.